Thursday, December 6, 2012

Stem cells as a new hype

From here
Drug companies and universities are spending 55.6 million euros ($72.7 million) to develop a bank of stem cells to use in testing potential treatments for hard-to- treat diseases.
The effort, known as Stembancc and managed by the University of Oxford in England, will focus on generating 1,500 induced pluripotent stem cell lines, researchers said at a London news conference. The cells will be used by drugmakers including Pfizer Inc. (PFE), Sanofi (SAN) and Roche Holding AG (ROG) to test treatments for peripheral nervous disorders, pain, dementia, migraine, autism, schizophrenia, bipolar disorder and diabetes and to perform toxicology tests.
Well, where is cancer? I mean it was usually acceptable that stem cells treatments have to be tested against cancer. The attempt of replacement of cancer tissue by stem cells is at least imaginable. What has happened that stem cells are not planned to be used against cancer?
The attempt of replacement of cancer tissue by stem cells is at least imaginable. But how in the world stem cells can be used for treatment of pain, dementia, migraine, autism, schizophrenia and bipolar disorder??? Something is disconnected here...

No comments:

Post a Comment